CVS Health Corp (CVS)
CVS Health Corp (CVS) carries a ŷRobot AI score of 61 out of 100. The model's fair value estimate is $90.48, 1.3% above the last close of $89.34. The chart signal reads Hold.
| Metric | CVS |
|---|---|
| AI score | 61 / 100 |
| Chart signal | Hold |
| Fair value estimate | $90.48 |
| Upside to fair value | 1.3% |
| Previous close | $89.34 |
| P/E | 9.29 |
| Price / sales | 0.25 |
| Market cap | $114.88B |
| EPS | 8.61 |
| Revenue growth | 7.0% |
| 1-year price change | 0.6% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about CVS
Is CVS overvalued or undervalued right now?
As of Nov 6, 2026, ŷRobot's fair-value model estimates CVS Health Corp (CVS) at $90.48 against a last close of $89.34, implying 1.3% upside to the model's estimate.
Is CVS's chart signal bullish or bearish?
The chart-signal model classifies CVS as Neutral as of Nov 13, 2026, with a signal score of -0.00 on a -1 to 1 scale.
What is CVS's ŷRobot AI score?
CVS scores 61 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is CVS stock expensive on P/E and P/S?
CVS trades at 9.3 times earnings and 0.3 times sales as of Nov 13, 2026.
What does CVS's seasonal forecast show?
ŷRobot's seasonal forecast curve for CVS reads +2.4% at 30 days, +1.3% at 90 days, and +0.6% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is CVS growing?
CVS Health Corp's revenue growth is +7.0% and free-cash-flow growth is +14.5% on the latest reported figures.
CVS chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.